Literature DB >> 27443134

World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.

Kurt W Prins1, Thenappan Thenappan2.   

Abstract

Pulmonary arterial hypertension (PAH) is a debilitating disease characterized by pathologic remodeling of the resistance pulmonary arteries, ultimately leading to right ventricular (RV) failure and death. In this article we discuss the definition of PAH, the initial epidemiology based on the National Institutes of Health Registry, and the updated epidemiology gleaned from contemporary registries, pathogenesis of pulmonary vascular dysfunction and proliferation, and RV failure in PAH.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Pathophysiology; Pulmonary arterial hypertension; Pulmonary vasculature; Right ventricle

Mesh：

Year:  2016        PMID： 27443134      PMCID： PMC4959804          DOI： 10.1016/j.ccl.2016.04.001

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN： 0733-8651            Impact factor:   2.213


  67 in total

Review 1.  The genetic basis of pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  Hum Genet       Date:  2014-01-21       Impact factor: 4.132

2.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

3.  Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.

Authors:  Lin Piao; Yong-Hu Fang; Kishan Parikh; John J Ryan; Peter T Toth; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2013-06-21       Impact factor: 4.599

4.  Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

Authors:  Syed H E Zaidi; Xiao-Mang You; Sorana Ciura; Mansoor Husain; Marlene Rabinovitch
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

5.  Alpha-skeletal actin messenger RNA increases in acute right ventricular hypertrophy.

Authors:  P R Bakerman; K R Stenmark; J H Fisher
Journal:  Am J Physiol       Date:  1990-04

6.  Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.

Authors:  John J Ryan; Jonathan D Rich; Thejasvi Thiruvoipati; Rajiv Swamy; Gene H Kim; Stuart Rich
Journal:  Am Heart J       Date:  2012-04       Impact factor: 4.749

7.  SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.

Authors:  R Ilkiw; L Todorovich-Hunter; K Maruyama; J Shin; M Rabinovitch
Journal:  Circ Res       Date:  1989-04       Impact factor: 17.367

8.  Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

Authors:  Yi Ling; Martin K Johnson; David G Kiely; Robin Condliffe; Charlie A Elliot; J Simon R Gibbs; Luke S Howard; Joanna Pepke-Zaba; Karen K K Sheares; Paul A Corris; Andrew J Fisher; James L Lordan; Sean Gaine; J Gerry Coghlan; S John Wort; Michael A Gatzoulis; Andrew J Peacock
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

9.  Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease.

Authors:  Kyoko Taniguchi; Chihiro Shimazaki; Yoshiko Fujimoto; Kazuho Shimura; Hitoji Uchiyama; Yosuke Matsumoto; Junya Kuroda; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2009-06-26       Impact factor: 2.490

10.  Microtubule proliferation in right ventricular myocytes of rats with monocrotaline-induced pulmonary hypertension.

Authors:  Rachel Stones; David Benoist; Michelle Peckham; Ed White
Journal:  J Mol Cell Cardiol       Date:  2012-12-21       Impact factor: 5.000
View more
  39 in total

1.  [The heart catheter table is not the operating table : Intraindividual comparison of pulmonary artery pressures].

Authors:  M U Ziegler; H Reinelt
Journal:  Anaesthesist       Date:  2018-04-05       Impact factor: 1.041

Review 2.  Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors:  Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

3.  Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.

Authors:  J A Jaffey; S B Leach; L R Kong; K E Wiggen; S B Bender; C R Reinero
Journal:  J Vet Cardiol       Date:  2019-05-11       Impact factor: 1.701

Review 4.  Neglected cardiovascular diseases and their significance in the Global North.

Authors:  Charle André Viljoen; Julian Hoevelmann; Elani Muller; Karen Sliwa
Journal:  Herz       Date:  2021-01-27       Impact factor: 1.443

Review 5.  Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies.

Authors:  Monika Spaczyńska; Susana F Rocha; Eduardo Oliver
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-01

6.  Pulmonary Arterial Hypertension and Therapeutic Interventions.

Authors:  Nader B Ishak Gabra; Omar Mahmoud; Oki Ishikawa; Varun Shah; Erica Altshul; Maly Oron; Bushra Mina
Journal:  Int J Angiol       Date:  2019-06-28

7.  Perspectives of bilateral thoracic sympathectomy for treatment of heart failure.

Authors:  Raphael Dos Santos Coutinho E Silva; Fernando Luiz Zanoni; Rafael Simas; Luiz Felipe Pinho Moreira
Journal:  Clinics (Sao Paulo)       Date:  2021-08-04       Impact factor: 2.365

8.  Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension.

Authors:  Kurtulus Karauzum; Irem Karauzum; Teoman Kilic; Tayfun Sahin; Canan Baydemir; Serap Baris Argun; Umut Celikyurt; Ulas Bildirici; Aysen Agir
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

9.  Echocardiographic assessment of pulmonary arterial capacitance predicts mortality in pulmonary hypertension.

Authors:  Alexander Papolos; Geoffrey H Tison; Jacob Mayfield; Elena Vasti; Teresa DeMarco
Journal:  J Cardiol       Date:  2020-11-04       Impact factor: 3.159

10.  Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Southern Taiwan: A Single-Center 10-Year Longitudinal Observation Cohort.

Authors:  Chun-Hsin Wu; Chun-Yu Lin; Chih-Hsin Hsu; Sheng-Hsiang Lin; Chia-Tse Weng
Journal:  Healthcare (Basel)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.